Stay updated on VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.

Latest updates to the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to reflect a new study involving VIC-1911 and sotorasib, with significant changes in the study's duration and assessment timelines, now focusing on a shorter 9-month period instead of the previous 42 months.SummaryDifference9%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of the study protocol for the VIC-1911 clinical trial, including specific details about the number of subjects anticipated in various cohorts and the removal of previous detailed descriptions of the study phases and inclusion criteria.SummaryDifference49%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.